104 related articles for article (PubMed ID: 25394485)
1. Cdc42 expression in cervical cancer and its effects on cervical tumor invasion and migration.
Ye H; Zhang Y; Geng L; Li Z
Int J Oncol; 2015 Feb; 46(2):757-63. PubMed ID: 25394485
[TBL] [Abstract][Full Text] [Related]
2. MiR-29a inhibits cell proliferation and migration by targeting the CDC42/PAK1 signaling pathway in cervical cancer.
Chen R; Zhang L
Anticancer Drugs; 2019 Jul; 30(6):579-587. PubMed ID: 30724771
[TBL] [Abstract][Full Text] [Related]
3. Plexin-B1 is a target of miR-214 in cervical cancer and promotes the growth and invasion of HeLa cells.
Qiang R; Wang F; Shi LY; Liu M; Chen S; Wan HY; Li YX; Li X; Gao SY; Sun BC; Tang H
Int J Biochem Cell Biol; 2011 Apr; 43(4):632-41. PubMed ID: 21216304
[TBL] [Abstract][Full Text] [Related]
4. The roles of Cdc42 and Rac1 in the formation of plasma membrane protrusions in cancer epithelial HeLa cells.
Ruiz-Lafuente N; Minguela A; Muro M; Parrado A
Mol Biol Rep; 2021 May; 48(5):4285-4294. PubMed ID: 34110575
[TBL] [Abstract][Full Text] [Related]
5. FOXF2 inhibits proliferation, migration, and invasion of Hela cells by regulating Wnt signaling pathway.
Zhang J; Zhang C; Sang L; Huang L; Du J; Zhao X
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30249755
[TBL] [Abstract][Full Text] [Related]
6. Effects of LncRNA Lnc-LIF-AS on cell proliferation, migration and invasion in a human cervical cancer cell line.
Song W; Wang J; Liu H; Zhu C; Xu F; Qian L; Shen Z; Zhu J; Yin S; Qin J; Chen L; Wu D; Nashan B; Shan G; Xiao W; Zhou Y
Cytokine; 2019 Aug; 120():165-175. PubMed ID: 31085454
[TBL] [Abstract][Full Text] [Related]
7. Expression analysis of Cdc42 in lung cancer and modulation of its expression by curcumin in lung cancer cell lines.
Chen QY; Jiao DM; Yao QH; Yan J; Song J; Chen FY; Lu GH; Zhou JY
Int J Oncol; 2012 May; 40(5):1561-8. PubMed ID: 22266952
[TBL] [Abstract][Full Text] [Related]
8. [Effect on invasion ability of cervical cancer cells after silence heparanase gene expression in Hela cells].
Lü QY; Zhang W; Cheng J; Zhang WT; Zhong YJ
Zhonghua Fu Chan Ke Za Zhi; 2013 Jul; 48(7):532-7. PubMed ID: 24284227
[TBL] [Abstract][Full Text] [Related]
9. Expression of transcription factor FOXC2 in cervical cancer and effects of silencing on cervical cancer cell proliferation.
Zheng CH; Quan Y; Li YY; Deng WG; Shao WJ; Fu Y
Asian Pac J Cancer Prev; 2014; 15(4):1589-95. PubMed ID: 24641373
[TBL] [Abstract][Full Text] [Related]
10. Expression of BMP7 in cervical cancer and inhibition of epithelial‑mesenchymal transition by BMP7 knockdown in HeLa cells.
Sun R; Guan H; Liu W; Liang J; Wang F; Li C
Int J Mol Med; 2020 May; 45(5):1417-1424. PubMed ID: 32323730
[TBL] [Abstract][Full Text] [Related]
11. [Inhibitory effect of bladder cancer related protein gene on HeLa cell proliferation].
Zuo ZH; Zhao M; Liu J; Wei Y; Wu XX
Ai Zheng; 2006 Jul; 25(7):811-7. PubMed ID: 16831269
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-26a inhibits cell proliferation and invasion of cervical cancer cells by targeting protein tyrosine phosphatase type IVA 1.
Dong J; Sui L; Wang Q; Chen M; Sun H
Mol Med Rep; 2014 Sep; 10(3):1426-32. PubMed ID: 24939702
[TBL] [Abstract][Full Text] [Related]
13. ALDH1 might influence the metastatic capability of HeLa cells.
Yao T; Lu R; Li Y; Peng Y; Ding M; Xie X; Lin Z
Tumour Biol; 2015 Sep; 36(9):7045-51. PubMed ID: 25864109
[TBL] [Abstract][Full Text] [Related]
14. A role for activated Cdc42 in glioblastoma multiforme invasion.
Okura H; Golbourn BJ; Shahzad U; Agnihotri S; Sabha N; Krieger JR; Figueiredo CA; Chalil A; Landon-Brace N; Riemenschneider A; Arai H; Smith CA; Xu S; Kaluz S; Marcus AI; Van Meir EG; Rutka JT
Oncotarget; 2016 Aug; 7(35):56958-56975. PubMed ID: 27486972
[TBL] [Abstract][Full Text] [Related]
15. XPNPEP2 is overexpressed in cervical cancer and promotes cervical cancer metastasis.
Cheng T; Wei R; Jiang G; Zhou Y; Lv M; Dai Y; Yuan Y; Luo D; Ma D; Li F; Xi L
Tumour Biol; 2017 Jul; 39(7):1010428317717122. PubMed ID: 28670957
[TBL] [Abstract][Full Text] [Related]
16. EGF upregulates Na+/H+ exchanger NHE1 by post-translational regulation that is important for cervical cancer cell invasiveness.
Chiang Y; Chou CY; Hsu KF; Huang YF; Shen MR
J Cell Physiol; 2008 Mar; 214(3):810-9. PubMed ID: 17894388
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA‑130a‑3p inhibition suppresses cervical cancer cell progression.
Causin RL; Van Helvoort Lengert A; Gomes INF; De Freitas AJA; Rosa MN; Dos Reis R; Reis RM; Marques MMC
Oncol Rep; 2023 May; 49(5):. PubMed ID: 37052265
[TBL] [Abstract][Full Text] [Related]
18. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect of shRNA targeting GPR48 on invasion and metastasis of human cervical carcinoma cell line HeLa.
Gao Y; Shan ZY; Wang H; Zhang HM; Teng WP
Ai Zheng; 2009 Feb; 28(2):104-7. PubMed ID: 19550120
[TBL] [Abstract][Full Text] [Related]
20. RECK inhibits cervical cancer cell migration and invasion by promoting p53 signaling pathway.
Liu Y; Li L; Liu Y; Geng P; Li G; Yang Y; Song H
J Cell Biochem; 2018 Apr; 119(4):3058-3066. PubMed ID: 29064588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
